Events & Presentations - GenomeFrontier Therapeutics, Inc.

Events & Presentations

Events

UPCOMING! Our founder/CEO/CSO, Sareina Wu, PhD and our COO/CSO Karen Wen, PhD will present our work as invited expert speakers at the 7th Annual CAR-TCR Summit in Boston, US. (September 19-23, 2022)
Read more
UPCOMING! Our founder/CEO/CSO, Sareina Wu, PhD and our COO/CSO Karen Wen, PhD will present our work as invited expert speakers at the 7th Annual CAR-TCR Summit in Boston, US. (September 19-23, 2022)
0
UPCOMING! Our founder/CEO/CSO, Sareina Wu, PhD will be an invited speaker at the Cell and Gene Therapy World Asia 2022 conference in Singapore. (September 14-15, 2022)
Read more
UPCOMING! Our founder/CEO/CSO, Sareina Wu, PhD will be an invited speaker at the Cell and Gene Therapy World Asia 2022 conference in Singapore. (September 14-15, 2022)
0
Our founder/CEO/CSO, Sareina Wu, PhD was an invited speaker at the 7th Cell & Gene Therapy Summit (Live Online via Zoom). (July 19-21, 2022)
Read more
Our founder/CEO/CSO, Sareina Wu, PhD was an invited speaker at the 7th Cell & Gene Therapy Summit (Live Online via Zoom). (July 19-21, 2022)
0
Our founder/CEO/CSO, Sareina Wu, PhD was invited to speak at the RASUS Global events: Next Generation Cell & Gene Therapy conference. (November 8-9, 2021)
Read more
Our founder/CEO/CSO, Sareina Wu, PhD was invited to speak at the RASUS Global events: Next Generation Cell & Gene Therapy conference. (November 8-9, 2021)
0
GenomeFrontier’s founder and Chief Scientific Officer, Dr. Sareina Wu, was recently interviewed by BioSpace for an article regarding non-viral vectors’ impact on CAR-T cell therapy.
Read more
GenomeFrontier’s founder and Chief Scientific Officer, Dr. Sareina Wu, was recently interviewed by BioSpace for an article regarding non-viral vectors’ impact on CAR-T cell therapy.
0
Published: Apr 05, 2021&nb […]